Current Advances in Minimally Invasive Surgical Management of Perihilar Cholangiocarcinoma.


Journal

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
ISSN: 1873-4626
Titre abrégé: J Gastrointest Surg
Pays: United States
ID NLM: 9706084

Informations de publication

Date de publication:
09 2020
Historique:
received: 06 04 2020
accepted: 30 04 2020
pubmed: 16 5 2020
medline: 15 4 2021
entrez: 16 5 2020
Statut: ppublish

Résumé

While the safety of minimally invasive surgery (MIS) has been reported for several liver malignancies, the role of MIS in the management of perihilar cholangiocarcinoma (pCCA) has been poorly defined. A systematic review of the literature was performed utilizing MEDLINE/PubMed and Web of Science databases up to January 2020 to assess the safety and feasibility of MIS in the management of patients with pCCA. Limited data exist on the MIS approach to treat pCCA. Staging laparoscopy carries a low diagnostic yield and typically is used only in select patients with high suspicion of metastatic disease. Data on the use of MIS approach for resection of pCCA have largely been limited to case reports or small case series. A MIS approach to pCCA resection has been demonstrated to be feasible and safe, yet in most series the surgeon failed to include resection of the caudate lobe. Given that caudate lobe involvement occurs in 31-98% of patients with pCCA, incomplete resection of the caudate lobe may be associated with higher local recurrence. More recently, several surgeons have reported complete R0 surgical with removal of the caudate lobe using a MIS approach. While patients may have a shorter length-of-stay, the true benefit of the MIS approach for pCCA needs to be better defined. MIS may be a safe and feasible approach at high-volume centers with robust expertise in the management of patients with pCCA. Further studies with larger number of patients are required prior to universal application of MIS for pCCA.

Sections du résumé

BACKGROUND
While the safety of minimally invasive surgery (MIS) has been reported for several liver malignancies, the role of MIS in the management of perihilar cholangiocarcinoma (pCCA) has been poorly defined.
METHODS
A systematic review of the literature was performed utilizing MEDLINE/PubMed and Web of Science databases up to January 2020 to assess the safety and feasibility of MIS in the management of patients with pCCA.
RESULTS
Limited data exist on the MIS approach to treat pCCA. Staging laparoscopy carries a low diagnostic yield and typically is used only in select patients with high suspicion of metastatic disease. Data on the use of MIS approach for resection of pCCA have largely been limited to case reports or small case series. A MIS approach to pCCA resection has been demonstrated to be feasible and safe, yet in most series the surgeon failed to include resection of the caudate lobe. Given that caudate lobe involvement occurs in 31-98% of patients with pCCA, incomplete resection of the caudate lobe may be associated with higher local recurrence. More recently, several surgeons have reported complete R0 surgical with removal of the caudate lobe using a MIS approach. While patients may have a shorter length-of-stay, the true benefit of the MIS approach for pCCA needs to be better defined.
CONCLUSIONS
MIS may be a safe and feasible approach at high-volume centers with robust expertise in the management of patients with pCCA. Further studies with larger number of patients are required prior to universal application of MIS for pCCA.

Identifiants

pubmed: 32410178
doi: 10.1007/s11605-020-04639-x
pii: 10.1007/s11605-020-04639-x
doi:

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2143-2149

Références

Levi Sandri GB, Spoletini G, Masciana G, Colasanti M, Lepiane P, Vennarecci G, et al. The role of minimally invasive surgery in the treatment of cholangiocarcinoma. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2017;43(9):1617-21.
doi: 10.1016/j.ejso.2017.02.012
Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet (London, England). 2014 383(9935):2168-79.
doi: 10.1016/S0140-6736(13)61903-0
Jarnagin WR, Shoup M, editors. Surgical management of cholangiocarcinoma. Seminars in liver disease; 2004: Copyright© 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New
He J, Amini N, Spolverato G, Hirose K, Makary M, Wolfgang CL, et al. National trends with a laparoscopic liver resection: results from a population-based analysis. HPB (Oxford). 2015;17(10):919-26.
pubmed: 26234323 pmcid: 4571760 doi: 10.1111/hpb.12469
Gouda B, Massol J, Fuks D, Gayet B. Minimally-invasive surgery for liver metastases. Minerva chirurgica. 2015;70(6):429-36.
pubmed: 26398066 pmcid: 26398066
Gaillard M, Tranchart H, Dagher I. Laparoscopic liver resections for hepatocellular carcinoma: current role and limitations. World journal of gastroenterology. 2014;20(17):4892-9.
pubmed: 24803800 pmcid: 4009520 doi: 10.3748/wjg.v20.i17.4892
Weber SM, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Staging laparoscopy in patients with extrahepatic biliary carcinoma: analysis of 100 patients. Annals of surgery. 2002;235(3):392.
pubmed: 11882761 pmcid: 1422445 doi: 10.1097/00000658-200203000-00011
Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary surgery and nutrition. 2014;3(1):18.
pubmed: 24696835 pmcid: 3955000
Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BJ, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234(4):507-17; discussion 17-9.
pubmed: 11573044 pmcid: 1422074 doi: 10.1097/00000658-200110000-00010
Tilleman EH, De Castro SM, Busch OR, Bemelman WA, Van Gulik TM, Obertop H, et al. Diagnostic laparoscopy and laparoscopic ultrasound for staging of patients with malignant proximal bile duct obstruction. Journal of Gastrointestinal Surgery. 2002;6(3):426-31.
pubmed: 12022996 doi: 10.1016/S1091-255X(02)00005-7 pmcid: 12022996
Connor S, Barron E, Wigmore SJ, Madhavan KK, Parks RW, Garden OJ. The utility of laparoscopic assessment in the preoperative staging of suspected hilar cholangiocarcinoma. Journal of gastrointestinal surgery. 2005;9(4):476-80.
pubmed: 15797226 doi: 10.1016/j.gassur.2004.10.009 pmcid: 15797226
Lewis HL, Rahnemai-Azar AA, Dillhoff M, Schmidt CR, Pawlik TM. Current management of perihilar cholangiocarcinoma and future perspectives. Chirurgia (Bucur). 2017;112(3):193-207.
pubmed: 28675356 doi: 10.21614/chirurgia.112.3.193 pmcid: 28675356
Mansour JC, Aloia TA, Crane CH, Heimbach JK, Nagino M, Vauthey JN. Hilar cholangiocarcinoma: expert consensus statement. HPB (Oxford). 2015;17(8):691-9.
pubmed: 26172136 pmcid: 4527854 doi: 10.1111/hpb.12450
Bird N, Elmasry M, Jones R, Elniel M, Kelly M, Palmer D, et al. Role of staging laparoscopy in the stratification of patients with perihilar cholangiocarcinoma. The British journal of surgery. 2017;104(4):418-25.
pubmed: 27861766 doi: 10.1002/bjs.10399 pmcid: 27861766
Russolillo N, D’Eletto M, Langella S, Perotti S, Lo Tesoriere R, Forchino F, et al. Role of laparoscopic ultrasound during diagnostic laparoscopy for proximal biliary cancers: a single series of 100 patients. Surgical Endoscopy. 2016;30(3):1212-8.
pubmed: 26139492 doi: 10.1007/s00464-015-4333-4 pmcid: 26139492
Goere D, Wagholikar GD, Pessaux P, Carrere N, Sibert A, Vilgrain V, et al. Utility of staging laparoscopy in subsets of biliary cancers : laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma. Surg Endosc. 2006;20(5):721-5.
pubmed: 16508808 doi: 10.1007/s00464-005-0583-x pmcid: 16508808
Barlow AD, Garcea G, Berry DP, Rajesh A, Patel R, Metcalfe MS, et al. Staging laparoscopy for hilar cholangiocarcinoma in 100 patients. Langenbeck’s archives of surgery. 2013;398(7):983-8.
pubmed: 23995711 doi: 10.1007/s00423-013-1104-3 pmcid: 23995711
Ruys AT, Busch OR, Gouma DJ, van Gulik TM. Staging laparoscopy for hilar cholangiocarcinoma: is it still worthwhile? Annals of surgical oncology. 2011;18(9):2647-53.
pubmed: 21347792 pmcid: 3162633 doi: 10.1245/s10434-011-1576-8
D'Angelica M, Fong Y, Weber S, Gonen M, DeMatteo RP, Conlon K, et al. The role of staging laparoscopy in hepatobiliary malignancy: prospective analysis of 401 cases. Ann Surg Oncol. 2003;10(2):183-9.
pubmed: 12620915 doi: 10.1245/ASO.2003.03.091 pmcid: 12620915
Rotellar F, Pardo F. Laparoscopic staging in hilar cholangiocarcinoma: Is it still justified? World journal of gastrointestinal oncology. 2013;5(7):127.
pubmed: 23919106 pmcid: 3731525 doi: 10.4251/wjgo.v5.i7.127
Puntambekar S, Sharma V, Kumar S, Mitkare S, Joshi G, Parikh H. Laparoscopic management of hilar cholangiocarcinoma: a case report. The Indian journal of surgery. 2016;78(1):57-9.
pubmed: 27186042 doi: 10.1007/s12262-015-1345-1 pmcid: 27186042
Lee W, Han HS, Yoon YS, Cho JY, Choi Y, Shin HK, et al. Laparoscopic resection of hilar cholangiocarcinoma. Ann Surg Treat Res. 2015;89(4):228-32.
pubmed: 26448923 pmcid: 4595825 doi: 10.4174/astr.2015.89.4.228
Lin E, Sarmiento JM. Laparoscopic extended right hepatectomy, portal lymphadenectomy, and hepaticojejunostomy for hilar cholangiocarcinoma. J Laparoendosc Adv Surg Tech A. 2014;24(6):411-6.
pubmed: 24784226 doi: 10.1089/lap.2013.0574 pmcid: 24784226
Gumbs AA, Jarufe N, Gayet B. Minimally invasive approaches to extrapancreatic cholangiocarcinoma. Surg Endosc. 2013;27(2):406-14.
pubmed: 22926892 doi: 10.1007/s00464-012-2489-8 pmcid: 22926892
Cho A, Yamamoto H, Kainuma O, Muto Y, Yanagibashi H, Tonooka T, et al. Laparoscopy in the management of hilar cholangiocarcinoma. World J Gastroenterol. 2014;20(41):15153-7.
pubmed: 25386064 pmcid: 4223249 doi: 10.3748/wjg.v20.i41.15153
Yu H, Wu SD, Tian Y, Su Y, Li YN. Single-incision laparoscopic resection of Bismuth I hilar cholangiocarcinoma. Surg Innov. 2013;20(3):209-13.
pubmed: 22393076 doi: 10.1177/1553350612438414 pmcid: 22393076
Machado MA, Makdissi FF, Surjan RC, Mochizuki M. Laparoscopic resection of hilar cholangiocarcinoma. J Laparoendosc Adv Surg Tech A. 2012;22(10):954-6.
pubmed: 23101791 doi: 10.1089/lap.2012.0339 pmcid: 23101791
Yu H, Wu SD, Chen DX, Zhu G. Laparoscopic resection of Bismuth type I and II hilar cholangiocarcinoma: an audit of 14 cases from two institutions. Dig Surg. 2011;28(1):44-9.
pubmed: 21293131 doi: 10.1159/000322398 pmcid: 21293131
Donati M, Stavrou GA, Oldhafer KJ. Laparoscopic resections for hilar cholangiocarcinomas: a critical appraisal. Dig Surg. 2011;28(4):277-8; author reply 9-80.
pubmed: 21778727 doi: 10.1159/000329583 pmcid: 21778727
Dinant S, Gerhards MF, Busch OR, Obertop H, Gouma DJ, Van Gulik TM. The importance of complete excision of the caudate lobe in resection of hilar cholangiocarcinoma. HPB (Oxford). 2005;7(4):263-7.
pubmed: 18333204 pmcid: 2043102 doi: 10.1080/13651820500372376
Abu Hilal M, Badran A, Di Fabio F, Pearce NW. Pure laparoscopic en bloc left hemihepatectomy and caudate lobe resection in patients with intrahepatic cholangiocarcinoma. J Laparoendosc Adv Surg Tech A. 2011;21(9):845-9.
pubmed: 21854201 doi: 10.1089/lap.2011.0247 pmcid: 21854201
Cai X, Li Z, Yu H, Liu K, Liang X, Wang Y, et al. Isolated laparoscopic resection of the hepatic caudate lobe. Chin Med J (Engl). 2014;127(17):3194-5.
pubmed: 25189971 pmcid: 25189971
Igami T, Komaya K, Hirose T, Ebata T, Yokoyama Y, Sugawara G, et al. Laparoscopic repeat hepatectomy after right hepatopancreaticoduodenectomy. Asian J Endosc Surg. 2016;9(3):211-4.
pubmed: 27221034 doi: 10.1111/ases.12282 pmcid: 27221034
Cho A, Yamamoto H, Kainuma O, Park S, Arimitsu H. Pure laparoscopic hepatopancreaticoduodenectomy for cholangiocarcinoma. Videoscopy. 2013;23(1):null.
Giulianotti PC, Sbrana F, Bianco FM, Addeo P. Robot-assisted laparoscopic extended right hepatectomy with biliary reconstruction. J Laparoendosc Adv Surg Tech A. 2010;20(2):159-63.
pubmed: 20201685 doi: 10.1089/lap.2009.0383 pmcid: 20201685
Zhu Z, Liu Q, Chen J, Duan W, Dong M, Mu P, et al. Robotic surgery twice performed in the treatment of hilar cholangiocarcinoma with deep jaundice: delayed right hemihepatectomy following the right-hepatic vascular control. Surg Laparosc Endosc Percutan Tech. 2014;24(5):e184-90.
pubmed: 24710222 doi: 10.1097/SLE.0b013e31828f708b pmcid: 24710222
Xu Y, Wang H, Ji W, Tang M, Li H, Leng J, et al. Robotic radical resection for hilar cholangiocarcinoma: perioperative and long-term outcomes of an initial series. Surg Endosc. 2016;30(7):3060-70.
pubmed: 27194255 doi: 10.1007/s00464-016-4925-7 pmcid: 27194255
Imamura H, Shimada R, Kubota M, Matsuyama Y, Nakayama A, Miyagawa S, et al. Preoperative portal vein embolization: an audit of 84 patients. Hepatology. 1999;29(4):1099-105.
pubmed: 10094953 doi: 10.1002/hep.510290415 pmcid: 10094953
Palavecino M, Abdalla EK, Madoff DC, Vauthey JN. Portal vein embolization in hilar cholangiocarcinoma. Surgical oncology clinics of North America. 2009;18(2):257-67, viii.
pubmed: 19306811 doi: 10.1016/j.soc.2008.12.007 pmcid: 19306811
Poruk KE, Pawlik TM, Weiss MJ. Perioperative management of hilar cholangiocarcinoma. J Gastrointest Surg. 2015;19(10):1889-99.
pubmed: 26022776 pmcid: 4858933 doi: 10.1007/s11605-015-2854-8
Are C, Iacovitti S, Prete F, Crafa FM. Feasibility of laparoscopic portal vein ligation prior to major hepatectomy. HPB. 2008;10(4):229-33.
pubmed: 18806869 pmcid: 2518294 doi: 10.1080/13651820802175261
Ayiomamitis GD, Low JK, Alkari B, Lee SH, Ammori BJ. Role of laparoscopic right portal vein ligation in planning staged or major liver resection. J Laparoendosc Adv Surg Tech A. 2009;19(3):409-13.
pubmed: 19215213 doi: 10.1089/lap.2008.0238 pmcid: 19215213
Levi Sandri GB, Colace L, Vennarecci G, Santoro R, Lepiane P, Colasanti M, et al. Laparoscopic first step approach in the two stage hepatectomy. Hepatobiliary surgery and nutrition. 2015;4(5):345-7.
pubmed: 26605282 pmcid: 4607831
Boggi U, Napoli N, Kauffmann EF, Presti GL, Moglia A. Laparoscopic microwave liver ablation and portal vein ligation: an alternative approach to the conventional ALPPS procedure in hilar cholangiocarcinoma. Ann Surg Oncol. 2016;23(Suppl 5):884.
pubmed: 27278201 doi: 10.1245/s10434-016-5297-x pmcid: 27278201
Goenka MK, Goenka U. Palliation: hilar cholangiocarcinoma. World J Hepatol. 2014;6(8):559-69.
pubmed: 25232449 pmcid: 4163739 doi: 10.4254/wjh.v6.i8.559
Yao D, Kunam VK, Li X. A review of the clinical diagnosis and therapy of cholangiocarcinoma. The Journal of international medical research. 2014;42(1):3-16.
pubmed: 24366497 doi: 10.1177/0300060513505488 pmcid: 24366497
Witzigmann H, Berr F, Ringel U, Caca K, Uhlmann D, Schoppmeyer K, et al. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg. 2006;244(2):230-9.
pubmed: 16858185 pmcid: 1602149 doi: 10.1097/01.sla.0000217639.10331.47
Witzigmann H, Lang H, Lauer H. Guidelines for palliative surgery of cholangiocarcinoma. HPB (Oxford). 2008;10(3):154-60.
pubmed: 18773044 pmcid: 2504365 doi: 10.1080/13651820801992567
Connor S, Wigmore SJ, Madhavan KK, Parks RW, Garden OJ. Surgical palliation for unresectable hilar cholangiocarcinoma. HPB (Oxford). 2005;7(4):273-7.
pubmed: 18333206 pmcid: 2043105 doi: 10.1080/13651820500372442
Toumi Z, Aljarabah M, Ammori BJ. Role of the laparoscopic approach to biliary bypass for benign and malignant biliary diseases: a systematic review. Surg Endosc. 2011;25(7):2105-16.
pubmed: 21298535 doi: 10.1007/s00464-010-1544-6 pmcid: 21298535
Ghanem AM, Hamade AM, Sheen AJ, Owera A, Al-Bahrani AZ, Ammori BJ. Laparoscopic gastric and biliary bypass: a single-center cohort prospective study. J Laparoendosc Adv Surg Tech A. 2006;16(1):21-6.
pubmed: 16494542 doi: 10.1089/lap.2006.16.21 pmcid: 16494542

Auteurs

Amir A Rahnemai-Azar (AA)

Division of Surgical Oncology, Department of Surgery, University of Wisconsin School of Medicine, Madison, WI, USA.

Arezou Abbasi (A)

Division of Surgical Oncology, Department of Surgery, University of Washington School of Medicine, Seattle, WA, USA.

Diamantis I Tsilimigras (DI)

Division of Surgical Oncology, Department of Surgery, The Ohio State University College of Medicine, Columbus, OH, USA.

Sharon M Weber (SM)

Division of Surgical Oncology, Department of Surgery, University of Wisconsin School of Medicine, Madison, WI, USA.

Timothy M Pawlik (TM)

Division of Surgical Oncology, Department of Surgery, The Ohio State University College of Medicine, Columbus, OH, USA. tim.pawlik@osumc.edu.
Department of Surgery, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, Surgery, Oncology, Health Services Management and Policy, The Ohio State University Wexner Medical Center, Columbus, OH, USA. tim.pawlik@osumc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH